Skip to content
Pardes Biosciences logo

Pardes Biosciences

YC top company

Pardes Biosciences is a YC Summer 2020 (S20) company. Based in San Francisco, CA, USA; Remote. Team of 2.

  • Biotech
  • Therapeutics

About Pardes Biosciences

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Pardes Biosciences develops oral antiviral drugs to treat and prevent viral infections, including COVID-19. The company focuses on small-molecule therapeutics that patients can take by mouth, replacing or supplementing injectable or hospital-administered antiviral options.

From the Y Combinator listing

How Pardes Biosciences describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

We break viruses

We make oral drugs to treat and prevent viral infections - like COVID-19.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
San Francisco, CA, USA; Remote
Team size
2
Status
Public
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works